Molecular Formula | C21H24N4O4 |
Molar Mass | 396.44 |
Density | 1.326 |
Boling Point | 701.9±60.0 °C(Predicted) |
Solubility | DMSO: soluble10mg/mL (clear solution) |
Appearance | powder |
Color | white to beige |
pKa | 4.72±0.10(Predicted) |
Storage Condition | room temp |
Use | PF-04620110 |
In vivo study | In rats, PF-04620110 at a dose of ≥ 0.1 mg/kg reduced plasma triglyceride levels after lipid stimulation. In rodents, inhibition of DGAT1 by PF-04620110 results in an enrichment of polyunsaturated fatty acids including triglyceride lipids. |
Hazard Symbols | Xn - Harmful |
Risk Codes | 22 - Harmful if swallowed |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.522 ml | 12.612 ml | 25.224 ml |
5 mM | 0.504 ml | 2.522 ml | 5.045 ml |
10 mM | 0.252 ml | 1.261 ml | 2.522 ml |
5 mM | 0.05 ml | 0.252 ml | 0.504 ml |
biological activity | PF-04620110 is an orally active, selective Diglyceride Acyltransferase -1(DGAT1) inhibitor, IC50 19 nM. PF-04620110 is an orally potent, selective Diglyceride Acyltransferase -1(DGAT1) inhibitor with an IC50 of 19 nM. |
Target | Value |
DGAT1 | 19 nM |